Business Segments MedCap AB

Stocks

MCAP

SE0009160872

Investment Management & Fund Operators

Market Closed - Nasdaq Stockholm 12:00:00 2026-10-02 EDT			5-day change	1st Jan Change
511.50 ^SEK	-0.39%		-3.03%	-6.83%

09-15	Odin Small Cap rose 4.15% in August, 16 holdings beat expectations	FW
09-09	PriorNilsson Evolve Global rose 0.49 percent in August, increased exposure to Kitron and Scanfil	FW

Sales 2025 by Business Segment

Sales 2025 by Geography

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Geographical Revenue Distribution History

Breakdown by Business Segment (SEK)

Fiscal Period: December	2021	2022	2023	2024	2025
Life Sciences Tools and Services
Assistive Tech	-	-	590M	767M	982M
Interest Expense	-	-	-9.1M	-9.6M	-14.4M
EBT	-	-	99.9M	155M	203M
EBITDA	-	-	146M	212M	290M
D&A	-	-	37M	47.8M	72.2M
Operating Income	-	-	109M	164M	217M
Medical Technology	600M	714M	512M	608M	690M
Interest Expense	-13.4M	-20M	-14.1M	-18.4M	-14.6M
Total Assets	-	-	-	-	-
EBT	112M	116M	50.4M	80.3M	88.6M
EBITDA	168M	190M	99M	138M	146M
D&A	42.7M	54.5M	34.5M	39.6M	42.7M
Operating Income	125M	136M	64.5M	98.7M	103M
	-	-	-	-	982M
	-	-	-	-	690M
Pharmaceutical Products
Specialty Medication	317M	397M	485M	432M	437M
Interest Expense	-6.9M	-9.4M	-13.1M	-11M	-12.8M
Total Assets	-	-	-	-	-
EBT	12.5M	51.8M	68.8M	22.3M	-3.6M
EBITDA	48.5M	90.3M	110M	59.2M	45.7M
D&A	29.2M	29.1M	28.1M	25.8M	36.5M
Operating Income	19.4M	61.2M	82M	33.4M	9.2M
Druo Trade	-	-	-	-	-
Interest Expense	-	-	-	-	-
Total Assets	-	-	-	-	-
EBT	-	-	-	-	-
EBITDA	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
	-	-	-	-	437M
Investment Funds
Abilia (Including Handitek)	-	-	-	-	-
Interest Expense	-	-	-	-	-
Total Assets	-	-	-	-	-
EBT	-	-	-	-	-
EBITDA	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Quickels	-	-	-	-	-
Interest Expense	-	-	-	-	-
Total Assets	-	-	-	-	-
EBT	-	-	-	-	-
EBITDA	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Unimedic	-	-	-	-	-
Interest Expense	-	-	-	-	-
Total Assets	-	-	-	-	-
EBT	-	-	-	-	-
EBITDA	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Inpac	-	-	-	-	-
Interest Expense	-	-	-	-	-
Total Assets	-	-	-	-	-
EBT	-	-	-	-	-
EBITDA	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Interest Expense	-	-	-	-	-
Total Assets	-	-	-	-	-
EBT	-	-	-	-	-
EBITDA	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Other and Elimination	-	-	-	-	-
Interest Expense	10.2M	10.5M	31.1M	28.3M	27.9M
Total Assets	-	-	-	-	-
EBT	-7.2M	-15.5M	3.1M	4.4M	1.1M
EBITDA	-13.8M	-21.8M	-23.5M	-21.7M	-24.8M
D&A	3.6M	4.2M	4.5M	2.2M	2M
Operating Income	-17.4M	-26M	-28M	-23.9M	-26.8M
Eliminations	-	-	-	-	-
Interest Expense	-	-	-	-	-
Total Assets	-	-	-	-	-
EBT	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-

Geographical breakdown of sales (SEK)

Fiscal Period: December	2021	2022	2023	2024	2025
Sweden	485M	558M	805M	898M	957M
Total Assets	388M	364M	511M	678M	659M
	-	-	-	-	612M
Nordic (Excl. Sweden)	195M	273M	345M	449M	612M
Total Assets	-	-	-	-	-
	-	-	-	-	53.7M
Europe (Excluding Scandinavia)	191M	226M	381M	385M	485M
	-	-	-	-	957M
Elsewhere in the world	45.6M	54.3M	57.2M	75.1M	53.7M
Total Assets	148M	153M	147M	163M	137M
Total Assets	112M	114M	104M	98.7M	87.8M
Total Assets	43.5M	52.4M	52.6M	87.8M	79.1M
Total Assets	-	-	79.1M	43.2M	183M
Total Assets	-	-	-	-	463M
	-	-	-	-	485M